Patient-derived scaffolds - a model for identifying cancer promoting properties of the tumor microenvironment relevant for cancer drug design and treatment prediction
High Throughout Mass Spectrometry (HTMS), combining Acoustic Ejection MS Innovation and Efficient Assay Development & Screening Capabilities to Accelerate Drug Discovery
Artificial intelligence in drug discovery: combining clinical and genomic data from cancer patients to identify genetic biomarkers and potential novel targets
Accelerating the drug development process with Bruker high-throughput mass spec solutions powered by timsTOF technology and Bruker SPR Pro: Multiple ways of kinetic profiling with High Throughput Surface Plasmon Resonance